Jonathan C. Fox, M.D., Ph.D., FACC

Jonathan C. Fox, M.D., Ph.D., FACC, has served as Board Member of ML Bio since ​October 2022. Jonathan Fox is the chief medical officer and therapeutic area lead of cardiovascular and renal diseases at BridgeBio. Prior to that, Dr. Fox served as the chief medical officer of MyoKardia, Inc. and as a senior advisor. Additionally, he worked as a consultant at Nigel-Montgomery and held various senior positions successively at SmithKline Beecham, Merck Research Laboratories and AstraZeneca. He was also on the faculty of the University of Pennsylvania School of Medicine. He currently holds an adjunct faculty position at the Stanford University Cardiovascular Institute. He received his A.B. in biology, his Ph.D. in medicine and pathology and his M.D. from the University of Chicago and completed his training in Internal Medicine and Cardiology at Duke University. Dr. Fox is ABIM Certified in Cardiovascular Diseases and is a Fellow of the American College of Cardiology.